Endothelial Cell Cystathionine γ-Lyase Expression Level Modulates Exercise Capacity, Vascular Function, and Myocardial Ischemia Reperfusion Injury.
Huijing Xia,Zhen Li,Thomas E. Sharp,David J. Polhemus,Jean Carnal,Karl H. Moles,Ya‐Xiong Tao,John Elrod,Josef Pfeilschifter,Karl‐Friedrich Beck,David J. Lefer
DOI: https://doi.org/10.1161/jaha.120.017544
IF: 6.106
2020-10-01
Journal of the American Heart Association
Abstract:Background Hydrogen sulfide (H 2 S) is an important endogenous physiological signaling molecule and exerts protective properties in the cardiovascular system. Cystathionine γ‐lyase (CSE), 1 of 3 H 2 S producing enzyme, is predominantly localized in the vascular endothelium. However, the regulation of CSE in vascular endothelium remains incompletely understood. Methods and Results We generated inducible endothelial cell‐specific CSE overexpressed transgenic mice (EC‐CSE Tg) and endothelial cell‐specific CSE knockout mice (EC‐CSE KO), and investigated vascular function in isolated thoracic aorta, treadmill exercise capacity, and myocardial injury following ischemia‐reperfusion in these mice. Overexpression of CSE in endothelial cells resulted in increased circulating and myocardial H 2 S and NO, augmented endothelial‐dependent vasorelaxation response in thoracic aorta, improved exercise capacity, and reduced myocardial‐reperfusion injury. In contrast, genetic deletion of CSE in endothelial cells led to decreased circulating H 2 S and cardiac NO production, impaired endothelial dependent vasorelaxation response and reduced exercise capacity. However, myocardial‐reperfusion injury was not affected by genetic deletion of endothelial cell CSE. Conclusions CSE‐derived H 2 S production in endothelial cells is critical in maintaining endothelial function, exercise capacity, and protecting against myocardial ischemia/reperfusion injury. Our data suggest that the endothelial NO synthase—NO pathway is likely involved in the beneficial effects of overexpression of CSE in the endothelium. Nonstandard Abbreviations and Acronyms CSE cystathionine γ‐lyase EC‐CSE KO endothelial cell‐specific CSE knockout EC‐CSE Tg endothelial cell‐specific CSE overexpressed transgenic eNOS endothelial NO synthase H 2 S hydrogen sulfide INF infarct size tTA tetracycline‐controlled trans‐activator Clinical Perspective What Is New? Cystathionine γ‐lyase is a critical enzyme responsible for generating hydrogen sulfide in endothelial cells. Hydrogen sulfide production in endothelial cells plays important role in maintaining cardiovascular function and protecting against myocardial ischemia/reperfusion injury. What Are the Clinical Implications? Modulation of endogenous endothelial hydrogen sulfide production could be a potential therapeutic strategy in the treatment of cardiovascular disease. Hydrogen sulfide (H 2 S), a highly toxic gas, is now recognized as an important endogenous physiological signaling molecule. At physiological levels, H 2 S exerts many protective properties in the cardiovascular system, including vasodilation, antioxidant, and anti‐inflammation. 1 , 2 , 3 , 4 The endogenous production of H 2 S is catalyzed by 3 enzymes: cystathionine β‐synthase, cystathionine γ‐lyase (CSE), and 3‐mercaptopyruvate sulfurtransferase. 5 While, all 3 enzymes have been found in the cardiovascular system, CSE is believed to be expressed primarily in the heart and vasculature and responsible for the majority endogenous H 2 S production in the cardiovascular system. 6 Therefore, it appeared that CSE is a critical enzyme that regulates H 2 S generation, and ultimately modulates cardiovascular function and health. Indeed, decreased CSE expression results in a global decrease in H 2 S bioavailability and is associated with multiple cardiovascular diseases. 7 , 8 G -Abstract Truncated-
cardiac & cardiovascular systems